Biopharma manufacturing poised to expand

Certain segments of the biopharmaceutical manufacturing industry are set to make big leaps in capacity over the next five years. Where will that expansion take place? Nope, not in Asia. Europe's the big beneficiary here. Report

Suggested Articles

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

Shionogi's newest antibiotic Fetroja has now earned the FDA's approval, but will a mortality-rate warning scuttle the drug's chances?

Novartis' Sandoz doubled down in Japan as Lupin retreated. Dr. Reddy's posted a loss tied to its Zantac recall. Aslan's varlitinib failed again.